Home » Archive by Category

News

Original content and news from BioSpace, Xconomy, Marketwire and other sources, specific to the region.

Thermo Fisher linked to Ebola test

August 7, 2014 – 9:48 pm | Edit Post

Rapid test for Ebola using technology from the company has been cleared for emergency use.

Dramatic Growth of Grafted Stem Cells in Rat Spinal Cord Injuries

August 7, 2014 – 9:00 am | Edit Post
Dramatic Growth of Grafted Stem Cells in Rat Spinal Cord Injuries

Building upon previous research, scientists at the University of California, San Diego School of Medicine and Veteran’s Affairs San Diego Healthcare System report that neurons derived from human induced pluripotent stem cells (iPSC) and grafted into rats after a spinal cord injury produced cells with tens of thousands of axons extending virtually the entire length of the animals’ central nervous system.

Dramatic Growth of Grafted Stem Cells in Rat Spinal Cord Injuries

August 7, 2014 – 9:00 am | Edit Post
Dramatic Growth of Grafted Stem Cells in Rat Spinal Cord Injuries

Building upon previous research, scientists at the University of California, San Diego School of Medicine and Veteran’s Affairs San Diego Healthcare System report that neurons derived from human induced pluripotent stem cells (iPSC) and grafted into rats after a spinal cord injury produced cells with tens of thousands of axons extending virtually the entire length of the animals’ central nervous system.

Dramatic Growth of Grafted Stem Cells in Rat Spinal Cord Injuries

August 7, 2014 – 9:00 am | Edit Post
Dramatic Growth of Grafted Stem Cells in Rat Spinal Cord Injuries

Building upon previous research, scientists at the University of California, San Diego School of Medicine and Veteran’s Affairs San Diego Healthcare System report that neurons derived from human induced pluripotent stem cells (iPSC) and grafted into rats after a spinal cord injury produced cells with tens of thousands of axons extending virtually the entire length of the animals’ central nervous system.

Dramatic Growth of Grafted Stem Cells in Rat Spinal Cord Injuries

August 7, 2014 – 9:00 am | Edit Post
Dramatic Growth of Grafted Stem Cells in Rat Spinal Cord Injuries

Building upon previous research, scientists at the University of California, San Diego School of Medicine and Veteran’s Affairs San Diego Healthcare System report that neurons derived from human induced pluripotent stem cells (iPSC) and grafted into rats after a spinal cord injury produced cells with tens of thousands of axons extending virtually the entire length of the animals’ central nervous system.

West Coast Biotech Roundup: MappBio, Juno, Zosano, and More

August 7, 2014 – 8:31 am | Edit Post
West Coast Biotech Roundup: MappBio, Juno, Zosano, and More

The IPO window is still open, sort of, but life sciences companies are not getting through unscathed. San Francisco-based Tobira Therapeutics and New York’s Microlin Bio postponed their offerings…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: MappBio, Juno, Zosano, and More

August 7, 2014 – 8:31 am | Edit Post
West Coast Biotech Roundup: MappBio, Juno, Zosano, and More

The IPO window is still open, sort of, but life sciences companies are not getting through unscathed. San Francisco-based Tobira Therapeutics and New York’s Microlin Bio postponed their offerings…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: MappBio, Juno, Zosano, and More

August 7, 2014 – 8:31 am | Edit Post
West Coast Biotech Roundup: MappBio, Juno, Zosano, and More

The IPO window is still open, sort of, but life sciences companies are not getting through unscathed. San Francisco-based Tobira Therapeutics and New York’s Microlin Bio postponed their offerings…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: MappBio, Juno, Zosano, and More

August 7, 2014 – 8:31 am | Edit Post
West Coast Biotech Roundup: MappBio, Juno, Zosano, and More

The IPO window is still open, sort of, but life sciences companies are not getting through unscathed. San Francisco-based Tobira Therapeutics and New York’s Microlin Bio postponed their offerings…

[[Click headline to continue reading.]]

Ebola treatment raises ethical issues

August 6, 2014 – 7:15 pm | Edit Post

The emergency treatment of two Ebola-infected American health workers with an experimental drug developed by a San Diego company is raising thorny ethical and practical questions about what to do for others stricken with the disease.